Breaking Braves’ Holmes Loses No-Hitter in Seventh Inning Against White Sox IDF Launches Criminal Investigation into Killing of Child, Relatives in Gaza US Deportations to Guatemala and Honduras Surge This Year Data Centers Emerge as Contentious Issue in U.S. Elections Cameroon’s President Biya Returns After Extended European Stay

Thursday August 20, 2026

Reporter

LEADS BIOLABS CO., LTD.

6Articles Published

5Communities Covered

Published Articles

Press Release

Leads Biolabs’ Opamtistomig (PD-L1/4-1BB Bispecific Antibody) Abstract Published by WCLC: Extended Follow‑Up Shows Continued Efficacy Improvement

4 hours ago

Press Release

Leads Biolabs’ Opamtistomig (PD-L1/4-1BB Bispecific Antibody) Abstract Published by WCLC: Extended Follow‑Up Shows Continued Efficacy Improvement

5 hours ago

Press Release

Leads Biolabs’ Opamtistomig (PD-L1/4-1BB Bispecific Antibody) Advances to Expansion Phase in First-Line Hepatocellular Carcinoma Following Positive Efficacy Signals

Aug 5

Press Release

Leads Biolabs Announces Partner Oblenio Bio Doses First Patients in Phase 1a Trial of LBL‑051 for Refractory Autoimmune Diseases

Aug 4

Press Release

Leads Biolabs’ PD-L1/4-1BB Bispecific Antibody IND Application for Combination Therapy in Metastatic Colorectal Cancer Approved, Further Strengthening Gastrointestinal Oncology Franchise

Aug 2

Press Release

Leads Biolabs’ Opamtistomig (PD-L1/4-1BB Bispecific Antibody) Completes Patient Enrollment in Phase II Study for Biliary Tract Cancer, Further Demonstrating Breakthrough Potential in Immune-Cold Tumors

Jul 30